First Time Loading...

Nephros Inc
NASDAQ:NEPH

Watchlist Manager
Nephros Inc Logo
Nephros Inc
NASDAQ:NEPH
Watchlist
Price: 1.99 USD -1.97% Market Closed
Updated: Apr 18, 2024

Intrinsic Value

NEPH doesn't have a meaningful market cap.

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. [ Read More ]

The intrinsic value of one NEPH stock under the Base Case scenario is 1.23 USD. Compared to the current market price of 1.99 USD, Nephros Inc is Overvalued by 38%.

Key Points:
NEPH Intrinsic Value
Base Case
1.23 USD
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Nephros Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NEPH stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Nephros Inc

Provide an overview of the primary business activities
of Nephros Inc.

What unique competitive advantages
does Nephros Inc hold over its rivals?

What risks and challenges
does Nephros Inc face in the near future?

Has there been any significant insider trading activity
in Nephros Inc recently?

Summarize the latest earnings call
of Nephros Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nephros Inc.

Provide P/S
for Nephros Inc.

Provide P/E
for Nephros Inc.

Provide P/OCF
for Nephros Inc.

Provide P/FCFE
for Nephros Inc.

Provide P/B
for Nephros Inc.

Provide EV/S
for Nephros Inc.

Provide EV/GP
for Nephros Inc.

Provide EV/EBITDA
for Nephros Inc.

Provide EV/EBIT
for Nephros Inc.

Provide EV/OCF
for Nephros Inc.

Provide EV/FCFF
for Nephros Inc.

Provide EV/IC
for Nephros Inc.

Show me price targets
for Nephros Inc made by professional analysts.

What are the Revenue projections
for Nephros Inc?

How accurate were the past Revenue estimates
for Nephros Inc?

What are the Net Income projections
for Nephros Inc?

How accurate were the past Net Income estimates
for Nephros Inc?

What are the EPS projections
for Nephros Inc?

How accurate were the past EPS estimates
for Nephros Inc?

What are the EBIT projections
for Nephros Inc?

How accurate were the past EBIT estimates
for Nephros Inc?

Compare the revenue forecasts
for Nephros Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nephros Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nephros Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nephros Inc compared to its peers.

Compare the P/E ratios
of Nephros Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Nephros Inc with its peers.

Analyze the financial leverage
of Nephros Inc compared to its main competitors.

Show all profitability ratios
for Nephros Inc.

Provide ROE
for Nephros Inc.

Provide ROA
for Nephros Inc.

Provide ROIC
for Nephros Inc.

Provide ROCE
for Nephros Inc.

Provide Gross Margin
for Nephros Inc.

Provide Operating Margin
for Nephros Inc.

Provide Net Margin
for Nephros Inc.

Provide FCF Margin
for Nephros Inc.

Show all solvency ratios
for Nephros Inc.

Provide D/E Ratio
for Nephros Inc.

Provide D/A Ratio
for Nephros Inc.

Provide Interest Coverage Ratio
for Nephros Inc.

Provide Altman Z-Score Ratio
for Nephros Inc.

Provide Quick Ratio
for Nephros Inc.

Provide Current Ratio
for Nephros Inc.

Provide Cash Ratio
for Nephros Inc.

What is the historical Revenue growth
over the last 5 years for Nephros Inc?

What is the historical Net Income growth
over the last 5 years for Nephros Inc?

What is the current Free Cash Flow
of Nephros Inc?

Financials

Balance Sheet Decomposition
Nephros Inc

Current Assets 8.4m
Cash & Short-Term Investments 4.3m
Receivables 1.5m
Other Current Assets 2.6m
Non-Current Assets 3.5m
PP&E 2m
Intangibles 1.4m
Other Non-Current Assets 86k
Current Liabilities 2.1m
Accounts Payable 873k
Accrued Liabilities 1.2m
Non-Current Liabilities 1.4m
Other Non-Current Liabilities 1.4m
Efficiency

Earnings Waterfall
Nephros Inc

Revenue
14.2m USD
Cost of Revenue
-5.8m USD
Gross Profit
8.4m USD
Operating Expenses
-10m USD
Operating Income
-1.6m USD
Other Expenses
18k USD
Net Income
-1.6m USD

Free Cash Flow Analysis
Nephros Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

NEPH Profitability Score
Profitability Due Diligence

Nephros Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
ROE is Increasing
29/100
Profitability
Score

Nephros Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

NEPH Solvency Score
Solvency Due Diligence

Nephros Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
48/100
Solvency
Score

Nephros Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NEPH Price Targets Summary
Nephros Inc

Wall Street analysts forecast NEPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEPH is 4.85 USD with a low forecast of 4.55 USD and a high forecast of 5.25 USD.

Lowest
Price Target
4.55 USD
128% Upside
Average
Price Target
4.85 USD
143% Upside
Highest
Price Target
5.25 USD
164% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NEPH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NEPH Price
Nephros Inc

1M 1M
-6%
6M 6M
+7%
1Y 1Y
+42%
3Y 3Y
-74%
5Y 5Y
-53%
10Y 10Y
-43%
Annual Price Range
1.99
52w Low
1.18
52w High
3.91
Price Metrics
Average Annual Return 0.15%
Standard Deviation of Annual Returns 85.38%
Max Drawdown -92%
Shares Statistics
Market Capitalization 21m USD
Shares Outstanding 10 544 100
Percentage of Shares Shorted 0.04%

NEPH Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Nephros Inc Logo
Nephros Inc

Country

United States of America

Industry

Consumer products

Market Cap

21m USD

Dividend Yield

0%

Description

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.

Contact

NEW JERSEY
South Orange
380 Lackawanna Pl
+12013435202.0
https://www.nephros.com/

IPO

2004-09-21

Employees

34

Officers

President, CEO & Director
Mr. Robert Banks
Chief Financial Officer
Ms. Judy F. Krandel C.F.A.
Director of Operations
Mr. Alfred Vargas
Director of Brand, Marketing & Business Development
Brianne McGuire
Vice President of Quality, Regulatory, & Human Resources
Vashone R. Thomas
Chief Executive Officer of Specialty Renal Products, Inc
Mr. Daron G. Evans M.B.A., M.S.
Show More
President of Aether Water Systems
Mr. Greg Lucas
Controller
Ms. Judy Mazzini
Show Less

See Also

Discover More
What is the Intrinsic Value of one NEPH stock?

The intrinsic value of one NEPH stock under the Base Case scenario is 1.23 USD.

Is NEPH stock undervalued or overvalued?

Compared to the current market price of 1.99 USD, Nephros Inc is Overvalued by 38%.